Logo image of HOVR

NEW HORIZON AIRCRAFT LTD (HOVR) Stock Fundamental Analysis

NASDAQ:HOVR - Nasdaq - CA64550A1075 - Common Stock - Currency: USD

1.81  -0.2 (-9.95%)

After market: 1.75 -0.06 (-3.31%)

Fundamental Rating

1

Overall HOVR gets a fundamental rating of 1 out of 10. We evaluated HOVR against 66 industry peers in the Aerospace & Defense industry. HOVR has a bad profitability rating. Also its financial health evaluation is rather negative. HOVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year HOVR was profitable.
HOVR had a negative operating cash flow in the past year.
HOVR Yearly Net Income VS EBIT VS OCF VS FCFHOVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

HOVR has a better Return On Assets (7.06%) than 77.27% of its industry peers.
HOVR has a Return On Equity (7.49%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 7.06%
ROE 7.49%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HOVR Yearly ROA, ROE, ROICHOVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HOVR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOVR Yearly Profit, Operating, Gross MarginsHOVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, HOVR has less shares outstanding
The debt/assets ratio for HOVR has been reduced compared to a year ago.
HOVR Yearly Shares OutstandingHOVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M
HOVR Yearly Total Debt VS Total AssetsHOVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 7.23 indicates that HOVR is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 7.23, HOVR is doing good in the industry, outperforming 78.79% of the companies in the same industry.
HOVR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
HOVR's Debt to Equity ratio of 0.00 is amongst the best of the industry. HOVR outperforms 93.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.23
ROIC/WACCN/A
WACCN/A
HOVR Yearly LT Debt VS Equity VS FCFHOVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

HOVR has a Current Ratio of 0.12. This is a bad value and indicates that HOVR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.12, HOVR is not doing good in the industry: 96.97% of the companies in the same industry are doing better.
HOVR has a Quick Ratio of 0.12. This is a bad value and indicates that HOVR is not financially healthy enough and could expect problems in meeting its short term obligations.
HOVR has a worse Quick ratio (0.12) than 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
HOVR Yearly Current Assets VS Current LiabilitesHOVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K 800K

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

HOVR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -20.38% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-57.08%
EPS Next 3Y-35.81%
EPS Next 5Y-20.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HOVR Yearly Revenue VS EstimatesHOVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
HOVR Yearly EPS VS EstimatesHOVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

HOVR is valuated cheaply with a Price/Earnings ratio of 4.76.
100.00% of the companies in the same industry are more expensive than HOVR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.92. HOVR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.76
Fwd PE N/A
HOVR Price Earnings VS Forward Price EarningsHOVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOVR Per share dataHOVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

HOVR's earnings are expected to decrease with -35.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-57.08%
EPS Next 3Y-35.81%

0

5. Dividend

5.1 Amount

HOVR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEW HORIZON AIRCRAFT LTD

NASDAQ:HOVR (6/24/2025, 8:00:02 PM)

After market: 1.75 -0.06 (-3.31%)

1.81

-0.2 (-9.95%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.34%
Inst Owner Change-59.16%
Ins Owners7.51%
Ins Owner Change0.82%
Market Cap56.82M
Analysts82.86
Price Target1.96 (8.29%)
Short Float %1.83%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.11%
PT rev (3m)-4.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.76
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)0.38
EY20.99%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS2.66
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.06%
ROE 7.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 7.23
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y-57.08%
EPS Next 3Y-35.81%
EPS Next 5Y-20.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16564%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y-78.1%
EBIT Next 5Y-72.92%
FCF growth 1Y-21149%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21149%
OCF growth 3YN/A
OCF growth 5YN/A